Mice, rats, guinea-pigs and rabbits were inoculated with isolates of Streptococcus suis type 2. An isolate cultured from the tonsils of a healthy pig, produced disease in rabbits after intravenous inoculation but not in mice, rats or guinea-pigs. An isolate of S. suis type 2, that was pathogenic for pigs and had been cultured from a human patient with clinical disease, produced signs of neurological disease in mice, rats and rabbits following intravenous inoculation. There was an apparent dose response in mice with 31 % of mice receiving more than 106 organisms developing clinical disease, whilst mice receiving less than this did not develop disease. There were no detectable histopathological lesions in the brains or meninges of mice with nervous signs. It is proposed that the disease in mice may mimic that reported in humans and that mice may be a useful indicator species for determining the virulence of isolates cultured from pigs.
INTRODUCTION
Streptococcus suis type 2 has mainly been associated with disease of pigs producing a meningitic, septicaemic and arthritic condition, however the organism can occasionally infect other species. StreptococcUs suis type 2 can produce disease in humans following infection via the percutaneous route, although disease occurs rarely [1] . The organism has also been isolated from a raccoon dog whose diet included uncooked pig meat originating from pigs which had died in piggeries with endemic streptococcal meningitis [2] . Hommez and colleagues [3] also isolated S. suis from cattle, sheep and goats, however only one isolate from a bovine was identified as being S. suis type 2. Although numerous experiments have demonstrated the virulence of this organism for pigs, there have been few trials investigating the virulence for other species. Williams and co-workers [4] demonstrated that mice could develop clinical signs of disease after intravenous inoculation with S. suis type 2. They showed that the infection could be transmitted to in-contact mice and that the disease appeared to mimic that seen in pigs. They proposed that mice may play a role in the epidemiology of the infection within a piggery. This paper reports on experiments carried out to determine the infectivity and pathogenicity of various isolates of S. suis type 2 for laboratory animals.
MATERIALS AND METHODS

Experimental animals
Laboratory mice (N.O.S.), rats (Sprague-Dawley), guinea-pigs and rabbits (New Zealand white) were used in this experiment. The mice were 6-12 weeks old, the rats and guinea pigs 10 weeks old and the rabbits 12-26 weeks old. Female guinea-pigs and rats were used, however the mice and rabbits were of both sexes. All animals appeared healthy prior to experimentation. The mice, rats and guineapigs all originated from the conventional non-barrier maintained Small Animal Breeding Colony, Massey University, whilst the rabbits were obtained from two local breeders with similar genetic stock.
The laboratory animals were housed in a heated, isolated room and examined twice daily for evidence of clinical signs of disease. They were autopsied within 3 weeks of inoculation, except for the offspring of some of the infected mice born during the experiment, which were killed between the age of 1 day and 1 month. Mice, rats and guinea-pigs were killed by gassing in a carbon dioxide chamber, whilst rabbits were destroyed with an intravenous injection of sodium pentobarbitone. The liver, kidney, spleen, heart blood, brain and the major joints (hip, shoulder, stifle and elbow) were cultured from each animal autopsied and samples of these tissues were collected for histopathological examination.
Infection procedure
Mice were infected by either the intraperitoneal route or by an intravenous injection into the coccygeal vein. Rats and guinea-pigs were infected by intracardiac injection. The rabbits were infected by an intravenous injection into the marginal ear vein. Prior to inoculation, xylene was rubbed on the ear to produce vasodilation.
Microorganisms
A porcine strain of S. suis type 2 that had been cultured from the palatine tonsils of an apparently healthy pig and a human strain of S. suis type 2 isolated from a patient with bacteraemia [5] were used in these experiments. The isolates were grown overnight in Todd Hewitt broth (GIBCO), and either inoculated directly into the laboratory animals or initially diluted in phosphate buffered saline.
Porcine strains of S. suis Eleven mice were inoculated intravenously with 01 ml containing 1-2 x 107 organisms of the porcine strain of S. suis type 2. Rats and guinea-pigs were inoculated with 6 x 107 organisms in a volume of 0 5 ml and four rabbits with 6 x 107 organisms of this isolate.
Human strain of S. suis type 2 Nine mice were inoculated via the intravenous route with 23 x 107 organisms in 0 5 ml, 14 mice with 4-6 x 107 and 10 each with 7-2 x 106, 1-8 x 104 and 45 organisms Pathogenicity of S. suis type 2. II 481 respectively in a volume of 041 ml. The intraperitoneal route was also used with eight mice receiving 23 x 107 organisms (0-5 ml), 10 with 4-6 x 107, seven with 7'2 x 106, 14 with 1P8 x 104 and 10 with 45 organisms in 0-1 ml. Four rats and three rabbits were also infected with 23 x 107 organisms of the human strain in a volume of 05 ml.
RESULTS
Mice, rats and guinea-pigs
In Table 1 the morbidity, mortality and cultural findings are reported for the laboratory animals inoculated with S. suis type 2. No clinical signs were observed in the mice, rats and guinea-pigs that received the porcine strain of S. suis type 2. However, two rats died within 2 min of being inoculated. One had a haemopericardium and the other was believed to have died from anaphylactic shock. Streptococcus suis type 2 was cultured from the heart blood and liver of both these rats. The bacterium was not cultured from any of the other mice, guinea-pigs and rats inoculated with this porcine strain.
Clinical disease and mortalities occurred in the mice inoculated with the human isolate. Signs of twitching, head bobbing and violent head movements were recorded from some (31 %) of the mice infected with more than 106 organisms by the intravenous or intraperitoneal routes. Streptococcus suis type 2 was cultured from the blood and/or brain of 15 of the 18 (83 %) mice with clinical disease and 12 of the 84 (14 %) apparently normal mice. Eight mice (two inoculated with the porcine isolate of S. suis type 2 and six with the human isolate) which were pregnant at the time of inoculation had apparently normal litters. These pregnant mice included two which had developed mild. neurological signs after intraperitoneal inoculation with the human isolate. The offspring of these mice appeared healthy and developed in a normal manner. Streptococcus suis type 2 was not cultured from these offspring. There was no significant difference between the number of mice developing clinical disease in the intraperitoneal inoculated group and the intravenous inoculated group (P > 0-4). No histopathological abnormalities were detected in the brains or meninges of the mice with clinical signs.
One of the rats infected with the human isolate died within 1 h of inoculation.
On autopsy it was found that this rat also had a haemopericardium. However, another rat developed signs of lethargy and depression 2 days after inoculation, and S. suis type 2 was cultured from all tissues and joints examined.
Rabbits
Two of the four rabbits inoculated with the porcine isolate were depressed, anorectic and not drinking 2 days after inoculation. These rabbits subsequently died 3 and 4 days after inoculation. The first rabbit to die had congested lymph nodes, parenchymatous organs and subcutaneous tissues, an excess of peritoneal fluid and petechial haemorrhages on the epicardium and myocardium. The stifle joints were hyperaemic with excessive joint fluid, however the other joints appeared normal. The second rabbit to die had congested hyperaemic lymph nodes with excessive pericardial and pleural fluid. One hip joint showed signs of congestion and hyperaemia, whilst the other joints appeared normal. Streptococcus suis type 2 was isolated from the joints and all tissues examined from these two rabbits. Five days after inoculation, the surviving two rabbits were lame, depressed and not eating or drinking. Streptococcus suis type 2 was not cultured from samples of blood collected 4, 5 and 6 days after inoculation. One rabbit was subsequently killed 7 days after experimental infection. On autopsy, a purulent arthritis was found in one stifle joint and S. suis type 2 was cultured from it. All other tissues and joints were sterile. The remaining rabbit was lame for another 2 weeks, however its appetite returned 2 days after the onset of clinical signs.
Streptococcus suis type 2 was not cultured from any tissues or joints.
All four rabbits inoculated with a human isolate ofS. suis type 2 developed signs of clinical disease. After intravenous inoculation of four rabbits with the human isolate of S. suis type 2, all developed clinical signs. Three of these rabbits died at 1, 2 and 4 days after inoculation respectively. All rabbits showed extensive subcutaneous haemorrhages and congestion of the parenchymatous organs and S. suis type 2 was cultured from all organs and joints sampled. Four days after inoculation, the surviving rabbit appeared to recover and continued to eat and drink normally until autopsied. No gross pathological changes could be detected in this rabbit and S. suis type 2 was not cultured from any tissues or joints.
DISCUSSION
Although the pathogenicity of S. suis type 2 has been widely reported for pigs, there are only a few studies on the pathogenicity of this organism for laboratory Pathogenicity of S. suis type 2. 48 animals. In the present study it was found that a porcine isolate was nonpathogenic for mice, rats and guinea-pigs when administered via the intravenous route. However, a human isolate was pathogenic for mice when administered via the intravenous or intraperitoneal route and for rats when administered by the intracardiac route. In mice inoculated with the human isolate, there appeared to be a dose response for the development of clinical signs with only mice receiving more than 106 organisms showing signs of disease. Similar findings were reported by Williams and co-workers [4] who showed that at least 108 organisms had to be inoculated intravenously for meningitis to develop in mice. These findings differ from those reported in pigs where there was no apparent dose response for the development of clinical disease following intranasal, intravenous or intracerebral inoculation with the same isolates [6] . Both porcine and human isolates of S. suis type 2 were pathogenic for rabbits when administered by the intravenous route.
Inoculation with S. sUis type 2 and the subsequent development of clinical signs in pregnant mice, had no effect on the survival of their subsequent litter. There was no detectable spread across the placenta, via the milk or from direct contact. These findings differ from those of Williams and co-workers [4] who demonstrated spread from infected to non-infected in-contact mice.
No inflammatory response was detected in histological sections taken from the brains of mice with nervous signs. Again this differs from the findings of Williams and colleagues [4] who reported a generalized diffuse meningitis similar to that recorded in clinically affected pigs. The findings in the present study may indicate that the organism produces a specific lesion in one region of the brain, rather than a generalized pathological change. The sections taken in the present study may not have included these specific areas and hence the brain would appear normal. In humans, it has been proposed that S. suis type 2 produces a neurotoxin that acts specifically against the eighth cranial nerve [7] . If this is the case for mice, a generalized inflammatory response would not be expected to be found as was the case in the present study.
In the present study, it was shown that S. suis type 2 could be cultured from the blood and/or brain of 14 % of clinically normal mice following intravenous or intraperitoneal inoculation with the human pathogenic isolate. These findings are similar to those reported by Robertson and Blackmore [6] who demonstrated that S. sUis type 2 could be cultured from the blood or brain of clinical normal pigs.
However as S. suis type 2 was not cultured from mice inoculated with nonpathogenic porcine isolates, it would appear that these isolates were not capable of lodging and multiplying within the mouse.
In a previous paper [6] , it was shown that the human isolate was capable of producing disease in pigs after intracerebral inoculation, whilst the porcine isolate could not. In the present study, the variable responses found after artificial infection of laboratory animals would indicate some differences in the pathogenicity of isolates. As rabbits appeared to be susceptible to infection with both pathogenic and non-pathogenic (for pigs) isolates of S. suis type 2, they would not be a good indicator for determining the pathogenicity of isolates for pigs. However as disease was only produced in mice after inoculation with isolates pathogenic for pigs, it is probable that mice are a better indicator species for determining the pathogenicity of isolates for pigs. 
